Similarly, a larger proportion of patients with DMO who required two or more consecutive anti‐VEGF injections had symptoms and risk factors of OSA than those who required only one injection (78%–88% vs. 50%). Here, VEGFA is linked to obstructive sleep apnea syndrome.